Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
12 2020
Historique:
received: 04 06 2020
revised: 09 06 2020
accepted: 12 06 2020
pubmed: 6 7 2020
medline: 19 12 2020
entrez: 6 7 2020
Statut: ppublish

Résumé

Systemic capillary leak syndrome is a rare disorder characterized by dysfunctional inflammatory response, endothelial dysfunction, and extravasation of fluid from the vascular space to the interstitial space leading to shock, hemoconcentration, hypoalbuminemia, and subsequent organ failure. The condition may be idiopathic or secondary to an underlying cause, which can include viral infections. Here we describe a patient with acute coronavirus disease 2019 (COVID-19) infection who presented with hemoconcentration, shock, and hypoalbuminemia. The patient subsequently developed rhabdomyolysis and compartment syndrome of all four extremities, requiring fasciotomies. This is the first reported case of systemic capillary leak syndrome associated with COVID-19 infection. This case adds to the evolving spectrum of inflammatory effects associated with this viral infection.

Identifiants

pubmed: 32622823
pii: S0012-3692(20)31845-6
doi: 10.1016/j.chest.2020.06.049
pmc: PMC7332444
pii:
doi:

Substances chimiques

Crystalloid Solutions 0
Vasoconstrictor Agents 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

e267-e268

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Références

Rev Med Interne. 2015 Jun;36(6):386-94
pubmed: 25600329
Intern Med. 2007;46(12):899-904
pubmed: 17575386
Mayo Clin Proc. 2010 Oct;85(10):905-12
pubmed: 20634497
Am J Med. 1960 Aug;29:193-216
pubmed: 13693909
J Infect. 2020 Jun;80(6):607-613
pubmed: 32283152
BMJ Case Rep. 2018 Aug 29;2018:
pubmed: 30158273
Ann Intern Med. 2010 Jul 20;153(2):90-8
pubmed: 20643990
Lancet. 2020 Jun 6;395(10239):1741-1743
pubmed: 32410759

Auteurs

Robert Case (R)

University of Florida Health, Gainesville, FL.

Aliaksandr Ramaniuk (A)

University of Florida Health, Gainesville, FL.

Pamela Martin (P)

University of Florida Health, Gainesville, FL.

Paul J Simpson (PJ)

University of Florida Health, Gainesville, FL.

Christopher Harden (C)

University of Florida Health, Gainesville, FL.

Ali Ataya (A)

University of Florida Health, Gainesville, FL. Electronic address: ali.ataya@medicine.ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH